
Mazkur maqolada 2-toifa qandli diabet fonida surunkali yurak yetishmovchiligi hamda uning o‘tkir dekompensatsiyasi bilan og‘rigan, chiqarish fraksiyasi pasaygan bemorlarni davolash masalasi tahlil qilinadi. Chiqarish fraksiyasi past bo‘lgan yurak yetishmovchiligi (ChFPYY) bugungi kunda eng muhim tibbiy va ijtimoiy muammolardan biri bo‘lib qolmoqda, ayniqsa u 2-toifa diabet bilan birgalikda kechganda. 2016 yilda sakubitril/valsartan kombinatsiyasi Yuperio savdo nomi ostida ro‘yxatdan o‘tkazildi va ushbu toifadagi bemorlarda kasalxonaga yotqizilish hamda o‘lim xavfini sezilarli darajada kamaytirishi isbotlandi. Keyinchalik farmatsevtika amaliyotida ushbu kombinatsiyaning qo‘llanilishi klinik amaliyotda kengayib bordi.
yurak yetishmovchiligi, o'tkir dekompensatsiya, sakubitril/valsartan (Yuperio), 2-toifa qandli diabet, surunkali buyrak yetishmovchiligi, chiqarish fraksiyasi past yurak yetishmovchiligi.
yurak yetishmovchiligi, o'tkir dekompensatsiya, sakubitril/valsartan (Yuperio), 2-toifa qandli diabet, surunkali buyrak yetishmovchiligi, chiqarish fraksiyasi past yurak yetishmovchiligi.
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
